CDRH Examining CryoLife Heart Valve Risks Following Tissue Recall
This article was originally published in The Gray Sheet
Executive Summary
CDRH is reviewing potential risks associated with CryoValve heart valves in the wake of an Aug. 14 recall order for CryoLife human tissue products